Diclofenac Sodium
NDC Package 67296-1480-7

11-digit billing NDC: 67296148007

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Diclofenac Sodium is carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Marketed by Redpharm Drug, Inc., this product is identified by NDC 67296-1480 and is authorized under FDA application ANDA077863.

Identification & Billing

NDC Package Code
67296-1480-7
Package Description
28 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
67296148007
RxNorm Crosswalk
RxCUI: 855926 - diclofenac sodium 75 MG Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Diclofenac Sodium
Dosage Form
-
Usage Information
Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration and Perforation). Diclofenac sodium delayed-release tablets are indicated:For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis

Regulatory & Marketing

Labeler Name
Redpharm Drug, Inc.
FDA Application #
ANDA077863
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-21-2015
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-1480-7 identifies a specific commercial package of 28 tablet, delayed release in 1 bottle of Diclofenac Sodium, labeled by Redpharm Drug, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug, Inc. on December 21, 2015. The current certification is valid through December 31, 2025.

How is this Redpharm Drug, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296148007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-1480-7
11-Digit CMS (5-4-2)
67296-1480-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.